Q3 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.360 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
ATNM | Actinium Pharmaceuticals, Inc. (Delaware) Common Stock | 8.45 | 0.14 | 1.68% | 112.9M |
You can purchase shares of Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (AMEX: ATNM) through any online brokerage.
There are no as such competitors for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock.
The latest price target for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (AMEX: ATNM) was reported by H.C. Wainwright on 2020-06-04. The analyst firm set a price target for 3.00 expecting ATNM to fall to within 12 months (a possible -63.90% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (AMEX: ATNM) is $8.31 last updated Fri Jan 15 2021 20:59:36 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock.
There is no upcoming split for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock.